Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with severe coronary artery disease
- 64 Downloads
Coronary artery disease (CAD) is still the preliminary cause of mortality and morbidity in the developed world. Identification of novel predictive and therapeutic biomarkers is crucial for accurate diagnosis, prognosis and treatment of the CAD. The aim of this study was to detect novel candidate miRNA biomarker that may be used in the management of CAD. We performed miRNA profiling in whole blood samples of angiographically confirmed Turkish men with CAD and non-CAD controls with insignificant coronary stenosis. Validation of microarray results was performed by qRT-PCR in a larger cohort of 62 samples. We subsequently assessed the diagnostic value of the miRNA and correlations of miRNA with clinical parameters. miRNA-target identification and network analyses were conducted by Ingenuity Pathway Analysis (IPA) software. Hsa-miR-584-5p was one of the top significantly dysregulated miRNA observed in miRNA microarray. Men-specific down-regulation (p = 0.040) of hsa-miR-584-5p was confirmed by qRT-PCR. ROC curve analysis highlighted the potential diagnostic value of hsa-miR-584-5p with a power area under the curve (AUC) of 0.714 and 0.643 in men and in total sample, respectively. The expression levels of hsa-miR-584-5p showed inverse correlation with stenosis and Gensini scores. IPA revealed CDH13 as the only CAD related predicted target for the miRNA with biological evidence of its involvement in CAD. This study suggests that hsa-miR-584-5p, known to be tumor suppressor miRNA, as a candidate biomarker for CAD and highlighted its putative role in the CAD pathogenesis. The validation of results in larger samples incorporating functional studies warrant further research.
KeywordsAtherosclerosis miRNA Microarray IPA T-Cadherin Stenosis
This study was supported by The Research Support Unit of Istanbul University as the Project Numbers: 51865 and 47372.
NC, DP designed and conducted the experiments. AFE. and BE contributed materials. NC, DP, BD contributed to data analysis and wrote the manuscript. NC, DP, BD, AFE and BE interpreted the results. All authors reviewed the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that there are no conflicts of interest.
- 1.Li Y, Wang DW, Chen Y, Chen C, Guo J, Zhang S, Sun Z, Ding H, Yao Y, Zhou L, Xu K, Song C, Yang F, Zhao B, Yan H, Wang WJ, Wu C, Lu X, Yang X, Dong J, Zheng G, Tian S, Cui Y, Jin L, Liu G, Cui H, Wang S, Jiang F, Wang C, Erdmann J, Zeng L, Huang S, Zhong J, Ma Y, Chen W, Sun J, Lei W, Chen S, Rao S, Gu D, Schunkert H, Tian XL (2018) Genome-wide association and functional studies identify SCML4 and THSD7A as novel susceptibility genes for coronary artery disease. Arterioscler Thromb Vasc Biol 38(4):964–975. https://doi.org/10.1161/ATVBAHA.117.310594 CrossRefPubMedGoogle Scholar
- 2.Zeller T, Seiffert M, Muller C, Scholz M, Schaffer A, Ojeda F, Drexel H, Mundlein A, Kleber ME, Marz W, Sinning C, Brunner FJ, Waldeyer C, Keller T, Saely CH, Sydow K, Thiery J, Teupser D, Blankenberg S, Schnabel R (2017) Genome-wide association analysis for severity of coronary artery disease using the gensini scoring system. Front Cardiovasc Med 4:57. https://doi.org/10.3389/fcvm.2017.00057 CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Malik R, Mushtaque RS, Siddiqui UA, Younus A, Aziz MA, Humayun C, Mansoor K, Latif MA, Waheed S, Assad S, Khan I, Bukhari SM, DelCampo D, Adus A, Gannarapu S (2017) Association between coronary artery disease and MicroRNA: literature review and clinical perspective. Cureus 9(4):e1188. https://doi.org/10.7759/cureus.1188 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Fils-Aime N, Dai M, Guo J, El-Mousawi M, Kahramangil B, Neel JC, Lebrun JJ (2013) MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-beta Mediates the migration and actin dynamics of breast cancer cells. J Biol Chem 288(17):11807–11823. https://doi.org/10.1074/jbc.M112.430934 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Xiang X, Mei H, Qu H, Zhao X, Li D, Song H, Jiao W, Pu J, Huang K, Zheng L (1852) Tong Q (2015) miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14. Biochim Biophys Acta 9:1743–1754. https://doi.org/10.1016/j.bbadis.2015.06.002 CrossRefGoogle Scholar
- 27.Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y, Dahiya R (2011) Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer 104(2):308–315. https://doi.org/10.1038/sj.bjc.6606028 CrossRefPubMedGoogle Scholar
- 32.Baulina N, Osmak G, Kiselev I, Popova E, Boyko A, Kulakova O, Favorova O (2019) MiRNAs from DLK1-DIO3 imprinted locus at 14q32 are associated with multiple sclerosis: gender-specific expression and regulation of receptor tyrosine kinases signaling. Cells 1:1. https://doi.org/10.3390/cells8020133 CrossRefGoogle Scholar
- 37.Kudrjashova E, Bashtrikov P, Bochkov V, Parfyonova Y, Tkachuk V, Antropova J, Iljinskaya O, Tararak E, Erne P, Ivanov D, Philippova M, Resink TJ (2002) Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis. Histochem Cell Biol 118(4):281–290. https://doi.org/10.1007/s00418-002-0463-6 CrossRefPubMedGoogle Scholar
- 41.Chotchaeva FRBAV, Samokhodskaya LM, Tkachuk VA, Sadovnichiy VA (2016) Association between T-cadherin gene (CDH13) variants and severity of coronary heart disease manifestation. Int J Clin Exp Med 9(2):4059–4064Google Scholar
- 43.Vargas-Alarcon G, Martinez-Rodriguez N, Velazquez-Cruz R, Perez-Mendez O, Posadas-Sanchez R, Posadas-Romero C, Pena-Duque MA, Martinez-Rios MA, Ramirez-Fuentes S, Fragoso JM (2017) The T%3eA (rs11646213) gene polymorphism of cadherin-13 (CDH13) gene is associated with decreased risk of developing hypertension in Mexican population. Immunobiology 222(10):973–978. https://doi.org/10.1016/j.imbio.2016.09.004 CrossRefPubMedGoogle Scholar
- 45.Faccini J, Ruidavets JB, Cordelier P, Martins F, Maoret JJ, Bongard V, Ferrieres J, Roncalli J, Elbaz M, Vindis C (2017) Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease. Sci Rep 7:42916. https://doi.org/10.1038/srep42916 CrossRefPubMedPubMedCentralGoogle Scholar
- 50.Ries J, Vairaktaris E, Kintopp R, Baran C, Neukam FW, Nkenke E (2014) Alterations in miRNA expression patterns in whole blood of OSCC patients. Vivo 28(5):851–861Google Scholar
- 51.Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513–10518. https://doi.org/10.1073/pnas.0804549105 CrossRefPubMedGoogle Scholar